EOLS News and Press, Evolus Inc. From 05/06/25

2025-05-06 17:20:54 ET More on Evolus Evolus: Two-Product Aesthetics Company With A Competitive Edge Evolus, Inc. 2024 Q4 - Results - Earnings Call Presentation Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript Evolus announces commercial launch of Evolyss...

2025-05-05 16:19:39 ET More on Evolus Evolus: Two-Product Aesthetics Company With A Competitive Edge Evolus, Inc. 2024 Q4 - Results - Earnings Call Presentation Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript Evolus announces commercial launch of Evolyss...

Refinanced Existing Credit Facility Drawing $150 Million at Close with $100 Million of Strategic Incremental Capacity Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it has entered into a...

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its first quarter 2025 financial results on Wednesday, May 7, 2025, after the U.S. financial markets close. Evolus management wil...

2025-04-22 19:10:44 ET Summary Evolus is expanding from a single product, Jeuveau, to include Evolysse dermal fillers, targeting younger, image-conscious consumers and leveraging FDA-approved weight loss wrinkle labeling. Evolus achieved record revenue in 2024 with $266.3 million,...

2025-04-16 08:25:04 ET More on Evolus Evolus, Inc. 2024 Q4 - Results - Earnings Call Presentation Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript Evolus announces Q4 preliminary unaudited net revenue of $79M Seeking Alpha’s Quant Rating on Evolus ...

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the commercial launch date for Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collec...

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the launch of its bold new campaign, “Drop the F Word,” ahead of the upcoming commercial launch of Evolysse ™ . Designed to challenge outdated perc...

2025-03-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will participate in a fireside chat and investor meetings at the upcoming Needham Annual Virtual Healthcare Conference. The fireside...